TABLE 2.
Primer name | Sequence (5′-3′) | Product size (bp) | Target gene/cluster |
---|---|---|---|
Efflux pump inactivation studya | |||
0035cF | CTGCACTTTCTCATGTAGAA | 809 | Cj0035c |
0035cR | GGCATTTACAAGTAAAATCA | ||
0309cF | GCGTGGTGATCATGAAAGAA | 228 | Cj0309c |
0309cR | CAGCGATTAAAAAAAGTTTC | ||
0309c-10cF | CGCTGTACAAGTAATAATCA | 591 | Cj0309c-Cj0310c |
0309c-10cR | TTAGGTGGAATTATAGAGTG | ||
0366cF | GCAATGATGCAGTTCCAATT | 1,166 | Cj0366c (cmeB) |
0366cR | GCCTGTGATACTTAATCCAG | ||
0560F | CTATAGGATCAGCAGTGCAA | 944 | Cj0560 |
0560R | TGCCTTATTAAAAGCTGTCA | ||
0619F | GGGATTTGCTTTCTAAGTAT | 1,210 | Cj0619 |
0619R | CCACGCAAAAACTCATCTGC | ||
1033F | CGACCTATTACCGTGCTAAT | 1,023 | Cj1033 |
1033R | GCAAGCAATGAGAGTTGTAC | ||
1173F | TTGCTGCTATTGTATTTGAA | 259 | Cj1173 |
1173R | CCAACGATAGAAAGAACAAT | ||
1173-4F | TTGCTGCTATTGTATTTGAA | 584 | Cj1173-Cj1174 |
1173-4R | CTGCTATTATCACGATAATG | ||
1241F | TGGCAGGAGTTTTGGTTGAT | 1,050 | Cj1241 |
1241R | AAGCAGGGCTTACAAAAAGT | ||
1257cF | TGGCTTATGCTTTAGGAACT | 545 | Cj1257c |
1257cR | CCCTCCAAGTCCTACACCTA | ||
1687F | CGGATTTAAAGCAGCTGTGT | 1,110 | Cj1687 |
1687R | ACAAGACCCATTTGTCTAAC | ||
16S 1a | AATACATGCAAGTCGAACGA | 1,004 | 16s rRNA |
16S 1b | TTAACCCAACATCTCACGAC | ||
gyrA mutation studyb | |||
upF | TGCTCTGCTTTTGTGAATTA | 850 | Cj1028c and gyrA |
86R | AAACTGCTGTATCTCCATGT | (ACA, Thr-86) | |
upF | TGCTCTGCTTTTGTGAATTA | 850 | Cj1028c and gyrA |
86mR | AAACTGCTATATCTCCATGT | (ATA, Ile-86) |
Boldface primers were used for efflux gene RT-PCR only.
Point mutation sites of interest are underlined.